Lupin Diagnostics expands its footprint in Central India

Global pharma major Lupin Limited (Lupin) announced the launch of its Regional Reference Laboratory in Indore, Madhya Pradesh, as part of its expansion in Central India. Lupin Diagnostics currently operates 325+ LupiMitra (Lupin’s franchise collection centers) and 23 laboratories in India.

The expansion in Indore is well-aligned with Lupin Diagnostics’ commitment to improving access to high-quality, reliable, and advanced testing centres and home collection facilities at an affordable price, a statement said.

In addition to routine and specialized tests, Lupin Diagnostics also offers molecular diagnostics, cytogenetics, flow cytometry, cytology, microbiology, serology, hematology, immunology, routine biochemistry and many more. These labs are equipped with qualified clinical experts and automated, streamlined processes so patients can make informed decisions about their health, the statement said.

Commenting on the launch, Ravindra Kumar, CEO – Lupin Diagnostics said, “The launch of our bestin-class regional reference lab in Indore marks our expansion into Central India. With this lab and collection centres in the region, we take the responsibility to provide superior pathology tests, curated health check packages and molecular diagnostics advanced testing facilities.”

“Accurate diagnosis is the key to identifying the right treatment. Our mission is to enable doctors to make informed decisions by providing advanced and high-quality diagnostics at an affordable price. Through our personalized and interactive smart reports, doctors and patients can analyse historical patterns in health parameters and guide treatment decisions based on evidence,” he added.

+ posts

HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.

What's your take on this post ? Comment: